Free Trial

Evofem Biosciences (EVFM) Competitors

Evofem Biosciences logo
$0.01 +0.00 (+10.99%)
As of 03:20 PM Eastern

EVFM vs. SNOA, PBM, QLGN, NLSP, CPHI, ONCO, KTTA, RDHL, APVO, and INM

Should you be buying Evofem Biosciences stock or one of its competitors? The main competitors of Evofem Biosciences include Sonoma Pharmaceuticals (SNOA), Psyence Biomedical (PBM), Qualigen Therapeutics (QLGN), NLS Pharmaceutics (NLSP), China Pharma (CPHI), Onconetix (ONCO), Pasithea Therapeutics (KTTA), Redhill Biopharma (RDHL), Aptevo Therapeutics (APVO), and InMed Pharmaceuticals (INM). These companies are all part of the "pharmaceutical products" industry.

Evofem Biosciences vs. Its Competitors

Sonoma Pharmaceuticals (NASDAQ:SNOA) and Evofem Biosciences (NASDAQ:EVFM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

Sonoma Pharmaceuticals has a net margin of -23.87% compared to Evofem Biosciences' net margin of -46.42%. Sonoma Pharmaceuticals' return on equity of -50.00% beat Evofem Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Sonoma Pharmaceuticals-23.87% -50.00% -16.79%
Evofem Biosciences -46.42%-91.97%-61.93%

In the previous week, Evofem Biosciences had 1 more articles in the media than Sonoma Pharmaceuticals. MarketBeat recorded 2 mentions for Evofem Biosciences and 1 mentions for Sonoma Pharmaceuticals. Sonoma Pharmaceuticals' average media sentiment score of 0.67 beat Evofem Biosciences' score of 0.60 indicating that Sonoma Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sonoma Pharmaceuticals
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Evofem Biosciences
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

2.0% of Sonoma Pharmaceuticals shares are held by institutional investors. Comparatively, 0.2% of Evofem Biosciences shares are held by institutional investors. 24.6% of Sonoma Pharmaceuticals shares are held by company insiders. Comparatively, 0.0% of Evofem Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Evofem Biosciences has lower revenue, but higher earnings than Sonoma Pharmaceuticals. Sonoma Pharmaceuticals is trading at a lower price-to-earnings ratio than Evofem Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sonoma Pharmaceuticals$14.29M0.42-$3.46M-$2.46-1.50
Evofem Biosciences$11.39M0.11$52.98M-$0.07-0.14

Sonoma Pharmaceuticals has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Comparatively, Evofem Biosciences has a beta of -1.13, indicating that its share price is 213% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonoma Pharmaceuticals
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Evofem Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Sonoma Pharmaceuticals beats Evofem Biosciences on 10 of the 14 factors compared between the two stocks.

Get Evofem Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVFM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVFM vs. The Competition

MetricEvofem BiosciencesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.28M$1.01B$6.17B$10.67B
Dividend YieldN/A4.84%5.72%4.86%
P/E Ratio-0.021.2529.6628.52
Price / Sales0.1129.59578.54129.10
Price / CashN/A17.6337.1261.42
Price / Book0.007.6912.046.52
Net Income$52.98M-$7.91M$3.32B$276.75M
7 Day PerformanceN/A-1.56%-0.16%0.20%
1 Month PerformanceN/A23.49%5.76%1.67%
1 Year PerformanceN/A-14.91%65.71%32.73%

Evofem Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVFM
Evofem Biosciences
1.4878 of 5 stars
$0.01
+11.0%
N/A-9.0%$1.28M$11.39M-0.02120
SNOA
Sonoma Pharmaceuticals
1.3222 of 5 stars
$4.00
-1.7%
N/A+29.1%$6.56M$14.29M-1.63180
PBM
Psyence Biomedical
0.4292 of 5 stars
$3.45
-3.2%
N/A-95.0%$6.44MN/A0.00N/AShort Interest ↑
Gap Down
QLGN
Qualigen Therapeutics
N/A$3.77
-6.0%
N/A-62.1%$6.41M$4.98M0.0050Negative News
NLSP
NLS Pharmaceutics
N/A$1.75
-1.1%
N/A-67.1%$6.30MN/A0.006News Coverage
Gap Down
CPHI
China Pharma
0.2377 of 5 stars
$1.86
-0.1%
N/A-93.1%$6.06M$4.40M0.00250Short Interest ↑
ONCO
Onconetix
0.2398 of 5 stars
$3.65
-1.0%
N/A-99.2%$5.65M$2.52M0.0012Short Interest ↑
KTTA
Pasithea Therapeutics
1.0428 of 5 stars
$0.75
+0.2%
N/A-83.0%$5.55MN/A-0.103Positive News
RDHL
Redhill Biopharma
N/A$1.62
-0.6%
N/A-79.1%$5.43M$8.04M0.00210News Coverage
Gap Down
APVO
Aptevo Therapeutics
0.2773 of 5 stars
$1.63
+1.6%
N/A-100.0%$5.35M$3.11M0.0050Gap Down
INM
InMed Pharmaceuticals
0.4639 of 5 stars
$2.18
+2.4%
N/A-67.7%$5.24M$4.94M-0.1810Short Interest ↑

Related Companies and Tools


This page (NASDAQ:EVFM) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners